No company operates in isolation, so it's essential to identify continuity risks, any potential bottlenecks, and any single points of failure. By building a simple, four-step action plan, manufacturers can manage the impact of the COVID-19 outbreak or a similar future event. These four steps include:
Founded in 1970 as a manufacturer of stainless steel tubes for medical injection needles, Teshima Sekan Co., Ltd. is one of the hottest companies boasting the industry's top market share in Japan with overwhelming technical capabilities. Currently, in addition to injections, it handles a wide range of medical devices and equipment, telecom equipment,automotive parts, etc., and in2017, was selected by the Ministry of Economy, Trade and Industry as a “Regional Future Leading Company”. Its technical capabilities are highly valued overseas.
This exhibition will bring together the latest technologies required to design and manufacture medical devices, such as metal/plastic processing technology, manufacturing equipment etc. It attracts a great number of medical device manufacturers and people who share the same enthusiasm for innovation in the Medical Sector.
Our CEO Yukiko Teshima will be visiting our US office all of next week. These visits are always very productive and somewhat hectic because of all the meetings and quantity of dicussion that we undergo while she is here. We have several meetings sectioned into different topics that we have to discuss. The Cambridge employees make compelling presentations whose topics range from what they have been doing on a daily basis to innovative ideas for the company's future. It is the best opportunity to make sure the Teshima global brand moves ahead in unison and that all employees are part of the success!